Back

Peripheral extracellular vesicle-derived miR-150-3p exacerbates acute kidney injury following acute pancreatitis by promoting ferroptosis through FTH1 signaling

Tao, C. J.; Sheng, W. G.; Sheng, Y. C.; Long, C.; Yu, G. X.; Jian, H. Z.; Xin, W. Z.; Gang, W.; Liang, J.; Sheng, T. D.

2023-01-17 cell biology
10.1101/2023.01.17.524353 bioRxiv
Show abstract

Acute kidney injury following acute pancreatitis (AP-AKI) is one of the most fatal complications caused by acute pancreatitis (AP). Extracellular vesicles (EVs) in circulating blood are believed to be crucial to the process of AP-AKI, but the mechanisms are still unclear. In this study, we first constructed an AP-AKI rat model by retrograde sodium taurocholate through the pancreatic duct and then injected circulating blood-derived EVs into AP-AKI rats. Measurements of peripheral blood creatinine and urea nitrogen levels showed that EVs could add to kidney injury in AP-AKI rats. By analyzing the levels of renal Fe2+, cyclooxygenase 2 (COX-2), malondialdehyde (MDA), and glutathione peroxidase 4 (GPX4), we also found that extracted EVs could aggravate renal tubular ferroptosis in AP-AKI rats. Using high-throughput sequencing, we screened for high expression of EV miR-150-3P in AP-AKI patients. In vitro, we found that overexpressed miR-150-3P can influence MDA, Fe2+, lipid peroxide and GSH levels in HK-2 cells and ultimately aggravate ferroptosis. Next, through a dual-luciferase assay, we confirmed that miR-150-3p could exacerbate ferroptosis by directly targeting ferritin heavy chain 1 (FTH1). Finally, in AP-AKI rats, we again demonstrated that overexpression of miR-150-3P exacerbated renal ferroptosis through the miR-150-3P/FTH1 axis. Collectively, these findings provide new avenues to explore the mechanisms of the onset and exacerbation of AP-AKI.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Acta Biochimica et Biophysica Sinica
23 papers in training set
Top 0.1%
19.5%
2
eLife
5828 papers in training set
Top 9%
10.2%
3
Cell Death & Disease
126 papers in training set
Top 0.1%
8.3%
4
Advanced Science
286 papers in training set
Top 0.9%
5.8%
5
Clinical and Translational Medicine
31 papers in training set
Top 0.1%
2.9%
6
Cells
249 papers in training set
Top 2%
2.2%
7
Protein & Cell
25 papers in training set
Top 0.2%
2.2%
50% of probability mass above
8
Redox Biology
70 papers in training set
Top 0.6%
2.1%
9
The FASEB Journal
194 papers in training set
Top 2%
2.0%
10
iScience
1154 papers in training set
Top 16%
1.8%
11
International Journal of Molecular Sciences
494 papers in training set
Top 7%
1.8%
12
PLOS ONE
5266 papers in training set
Top 51%
1.5%
13
Journal of Cellular Physiology
25 papers in training set
Top 0.3%
1.4%
14
Frontiers in Molecular Biosciences
102 papers in training set
Top 1%
1.2%
15
Theranostics
37 papers in training set
Top 0.6%
1.2%
16
Journal of Biomedical Science
17 papers in training set
Top 0.2%
1.2%
17
Heliyon
152 papers in training set
Top 5%
1.2%
18
Journal of the American Society of Nephrology
56 papers in training set
Top 0.5%
1.2%
19
Cell Discovery
57 papers in training set
Top 0.8%
1.1%
20
Stem Cell Research & Therapy
30 papers in training set
Top 0.6%
1.0%
21
Toxins
14 papers in training set
Top 0.1%
0.9%
22
JCI Insight
277 papers in training set
Top 7%
0.9%
23
Journal of Molecular Cell Biology
22 papers in training set
Top 0.3%
0.9%
24
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26 papers in training set
Top 0.7%
0.9%
25
Cell Death Discovery
58 papers in training set
Top 1%
0.9%
26
Arteriosclerosis, Thrombosis, and Vascular Biology
71 papers in training set
Top 1%
0.6%
27
Respiratory Research
21 papers in training set
Top 0.4%
0.6%
28
Scientific Reports
3612 papers in training set
Top 77%
0.6%
29
Genomics, Proteomics & Bioinformatics
172 papers in training set
Top 2%
0.6%
30
Biogerontology
10 papers in training set
Top 0.3%
0.6%